LAUSR

"Nail loss after teriflunomide treatment: A new potential adverse event".

Sign Up to like & get
recommendations!
1 Published in 2017 at "Multiple sclerosis and related disorders"

DOI: 10.1016/j.msard.2017.09.029

Abstract: Nail loss might represent a new, reversible, adverse event associated with teriflunomide treatment. It shares close analogies with hair loss and thinning, known adverse events of teriflunomide. MS specialists should be aware of this possibility… read more here.

Keywords: nail loss; adverse event; treatment; teriflunomide treatment ... See more keywords